Pfizer holds lead in erectile dysfunction market as Viagra sales fall

Despite competition from other drugmakers, Pfizer has been able to maintain a significant share in the erectile dysfunction market thanks in part to launching its own generic version of the blue, diamond-shaped pill.

Global Erectile Dysfunction Drugs Market To Grow At A CAGR Of 6.9% During The Projection Period.

Canada's Supreme Court strips Viagra patent from Pfizer

Viagra - Erectile Dysfunction, Side Effects, & Drug Interactions

Drugs For Erectile Dysfunction Global Market Report 2023

What to know about generic Viagra

The Hard Truth: What Viagra Was Really Intended For

Contribution of sewage to occurrence of phosphodiesterase-5 inhibitors in natural water

Hims and Roman Target Erectile Dysfunction, Which Can Signal Health Issues

Viagra: Is The Blue Pill Finally Losing Its Potency?

Hard-up Russia pushes to replenish sagging Viagra supply

The Little Blue Pill: An Oral History of Viagra - Bloomberg

How Viagra's Erectile Dysfunction Pills for Men Became A Multi-Billion-Dollar Industry

Erectile Dysfunction (ED) Drugs Market Size, Share [2024-2028 Report]

Viagra: How a Little Blue Pill Changed the World